[HTML][HTML] Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings

…, EA Rowley, P Patel, O Zerbo, EP Griggs… - … England Journal of …, 2021 - Mass Medical Soc
Background There are limited data on the effectiveness of the vaccines against symptomatic
coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect …

Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

…, SE Reese, PJ Embi, K Dascomb, NP Klein, EP Griggs… - bmj, 2022 - bmj.com
Objective To estimate the effectiveness of mRNA vaccines against moderate and severe
covid-19 in adults by time since second, third, or fourth doses, and by age and …

Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA. 4 and BA. 5 sublineage periods

…, MA Barron, K Murthy, J Nanez, EP Griggs… - JAMA network …, 2023 - jamanetwork.com
Importance Recent SARS-CoV-2 Omicron variant sublineages, including BA.4 and BA.5,
may be associated with greater immune evasion and less protection against COVID-19 after …

Effectiveness of BNT162b2 COVID-19 vaccination in children and adolescents

…, B Fireman, J Arndorfer, NR Valvi, EP Griggs… - …, 2023 - publications.aap.org
OBJECTIVES We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate
and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the …

Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021–2022 season, VISION Network

…, P Patel, J Timbol, EP Griggs… - The Journal of …, 2023 - academic.oup.com
Background Following historically low influenza activity during the 2020–2021 season, the
United States saw an increase in influenza circulating during the 2021–2022 season. Most …

[HTML][HTML] Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA. 1 variant …

…, NR Valvi, MM Dunne, EP Griggs… - The Lancet Regional …, 2023 - thelancet.com
Background Understanding the usefulness of additional COVID-19 vaccine doses—particularly
given varying disease incidence—is needed to support public health policy. We …

Protection of two and three mRNA vaccine doses against severe outcomes among adults hospitalized with COVID-19—Vision Network, August 2021 to March 2022

…, B Fireman, IJ Essien, EP Griggs… - The Journal of …, 2023 - academic.oup.com
Background We assessed coronavirus disease 2019 (COVID-19) vaccination impact on
illness severity among adults hospitalized with COVID-19, August 2021–March 2022. Methods …

Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness

…, G Vazquez-Benitez, IC Liao, EP Griggs… - Clinical Infectious …, 2023 - academic.oup.com
Background Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in
communities with higher social vulnerability. Factors such as severe acute respiratory …

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States …

EP Griggs, PK Mitchell, V Lazariu… - Clinical Infectious …, 2024 - academic.oup.com
Background The epidemiology of coronavirus disease 2019 (COVID-19) continues to develop
with emerging variants, expanding population-level immunity, and advances in clinical …

Symptoms and recovery among adult outpatients with and without COVID‐19 at 11 healthcare facilities—July 2020, United States

…, ER Smith, SS Kim, EP Griggs… - Influenza and other …, 2021 - Wiley Online Library
Background Symptoms of mild COVID‐19 illness are non‐specific and may persist for prolonged
periods. Effects on quality of life of persistent poor physical or mental health associated …